The Role of Bundles in Sepsis Care

Critical Care Clinics

Volumn 22, Issue 3, 2006, Pages 521-529

  Hurtado, Francisco Javier ^a   Nin, Nicolás ^a  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; CORTICOTROPIN; DOBUTAMINE; DROTRECOGIN; GLUCOCORTICOID; HYDROCORTISONE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; INSULIN; NORADRENALIN; STEROID;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; BLEEDING; BLOOD CULTURE; CLINICAL TRIAL; COLLOID; CRYSTALLOID; DIABETES MELLITUS; FLUID THERAPY; GASTROINTESTINAL HEMORRHAGE; GLYCEMIC CONTROL; HEMATOCRIT; HEMODYNAMICS; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOTENSION; LACTATE BLOOD LEVEL; MEASUREMENT; MORTALITY; OXYGEN SATURATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESUSCITATION; REVIEW; RISK REDUCTION; SEPSIS; SEPTIC SHOCK; SUPERINFECTION; SURVIVAL; TIDAL VOLUME; TISSUE PERFUSION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BLOOD GLUCOSE; CLINICAL PROTOCOLS; CRITICAL CARE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUID THERAPY; HUMANS; HYPOTENSION; LACTIC ACID; PROTEIN C; RECOMBINANT PROTEINS; RESPIRATION, ARTIFICIAL; RESUSCITATION; SEPSIS; STEROIDS; VASOCONSTRICTOR AGENTS;

EID: 33746835326     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2006.03.005     Document Type: Review

References (45)

1. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 (2001) 1368-1377
2. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 (2004) 858-873
3. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 30 (2004) 536-555
4. Cabana M.D., Rand C.S., Powe N.R., et al. Why dońt physicians follow clinical practice guidelines? A framework for improvement. JAMA 282 (1999) 1458-1465
5. Levy M.M., Provonost P.J., Dellinger R.P., et al. Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med 32 (2004) S595-S597
6. Gao F., Melody T., Daniels D.F., et al. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care 9 (2005) R764-R770
7. Bakker J., Coffernils M., Leon M., et al. Blood lactate levels are superior to oxygen derived variables in predicting outcome in human septic shock. Chest 99 (1991) 956-962
8. Friedman G., Berlot G., Kahn R.J., et al. Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis. Crit Care Med 23 (1995) 1184-1193
9. Vincent J.L., and Gerlach H. Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med 32 (2004) S451-S454
10. Bochud P.Y., Bonten M., Marchetti O., et al. Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review. Crit Care Med 32 (2004) S495-S512
11. Cohen J., Brun-Buisson C., Torres A., et al. Diagnosis of infection in sepsis: an evidence-based review. Crit Care Med 32 (2004) S466-S494
12. Ibrahim E.H., Sherman G., Ward S., et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118 (2000) 146-155
13. Kollef M.H., Sherman G., Ward S., et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115 (1999) 462-474
14. Leibovici L., Shraga I., Ducker M., et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244 (1998) 379-386
15. Reinhart K., Kuhn H.J., Hartog C., et al. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med 30 (2004) 1572-1578
16. Rivers E.P., McIntyre L., Morro D.C., et al. Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ 173 (2005) 1054-1065
17. Choi P.T., Yip G., Quinonez L.G., et al. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 27 (1999) 200-210
18. Cook D., and Guyatt G. Colloid use for fluid resuscitation: evidence and spin. Ann Intern Med 135 (2001) 205-208
19. Finfer S., Bellomo R., Boyce N., et al. A comparison of albumin ad saline for fluid resuscitation in the intensive care unit. N Engl J Med 350 (2004) 2247-2256
20. Beale R.J., Hollenberg S.M., Vincent J.L., et al. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med 32 (2004) S455-S465
21. Levy B., Bollaert P.E., Charpentier C., et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock. Intensive Care Med 23 (1997) 282-287
22. Zhou S.X., Qiu H.B., Huang Y.Z., et al. Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock. Acta Pharmacol Sin 23 (2002) 654-658
23. 2 Collaborative Group. N Engl J Med 333 (1995) 1025-1032
24. Sprung C.L., Carlis P.V., Marcial E.H., et al. The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study. N Engl J Med 311 (1984) 1137-1143
25. Keh D., and Sprung C.L. Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review. Crit Care Med 32 (2004) S527-S533
26. Lefering R., and Neugebauer E.A. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 23 (1995) 1294-1303
27. Hollenberg S.M., Ahrens T.S., Annane D., et al. Practice parameters for hemodynamic support of sepsis in adult patients. Crit Care Med 32 (2004) 1928-1948
28. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002) 862-871
29. Briegel J., Forst H., Haller M., et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27 (1999) 723-732
30. Yildiz O., Dogonay M., Aygen B., et al. Physiological-dose steroid therapy in sepsis. Crit Care 6 (2002) 251-259
31. Rubenfeld G.D. When survival is not the same as mortality. Critical Care Alert 10 (2003) 113-115
32. Annane D., Bellisant E., Bollaert P.E., et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 329 (2004) 480
33. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 (2001) 699-709
34. Angus D.C., Laterre P.F., Helterbrand J., et al. The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis. Crit Care Med 32 (2004) 2199-2206
35. Warren H.S., Suffredini A.F., Eichacker P.Q., et al. Risks and benefits of activated protein C treatment for severe sepsis. N Engl J Med 347 (2002) 1027-1030
36. Fourrier F. Recombinant human activated protein C in the treatment of severe sepsis: an evidence-based review. Crit Care Med 32 (2004) S534-S541
37. Cariou A., Vinsonneau C., and Dhainaut J.F. Adjunctive therapies in sepsis: an evidence-based review. Crit Care Med 32 (2004) S562-S570
38. Cely C.M., Arora P., Quartin A.A., et al. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest 126 (2004) 879-887
39. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
40. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
41. Esteban A., Anzueto A., Frutos F., et al. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA 287 (2002) 345-355
42. Nin N., Penuelas O., De Paula M., et al. Ventilation-induced lung injury in rats is associated with organ injury and systemic inflammation that is attenuated by dexamethasone. Crit Care Med 34 (2006) 1093-1098
43. Imai Y., Parodo J., Kajikawa O., et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 289 (2003) 2104-2112
44. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342 (2000) 1301-1308
45. Sevransky J.E., Levy M.M., and Marini J.J. Mechanical ventilation in sepsis-induced acute lung injury/acute respiratory distress syndrome: an evidence-based review. Crit Care Med 32 (2004) S548-S553